C-myc required by the imm...( Lausanne c-myc a gene commonly involv...),Health

Lausanne c-myc, a gene commonly involved in cancer onset, has been found to have a role in the immune system's normal function according to a study published today in Blood. The surprising finding, by a Swiss research team led by investigators from the Lausanne Branch of the international Ludwig Institute for Cancer Research (LICR), showed that c-myc functions in the immune system's 'memory' of previous infections.

In order to rapidly and efficiently respond to new infections, the immune system evolved such that it stores a 'memory' of previous attack by pathogens. The specialized cells involved in this process are known as 'T memory cells'. The T memory cells are normally maintained at a low level that can be rapidly expanded if the pathogen is detected again. The maintenance of normal, low levels, or 'homeostasis', of T memory cells is dependent on a signalling factor, a so-called cytokine, known as 'IL- 15.

"Very little is known about the signalling pathways that actually control IL-15-dependent homeostasis," explains LICR's Dr. H. Robson MacDonald, the senior author of the study. "By analyzing genetically engineered mouse models with reduced c-myc, reduced IL-15 or absent IL-15, we discovered that it's actually c-myc, which is known primarily as an oncogene, that acts downstream of the IL-15 signaling pathway to regulate T memory cell homeostasis."

According to Dr. MacDonald, the study is basic research that may have implications for therapies of the future. "Understanding how immune memory works might allow us to improve therapeutic vaccines against, say, malaria or cancer. The unexpected finding is that this study is also a cautionary tale. Before we design new therapies that inactivate a gene product, which is an approach being considered for c-myc in cancer, we need to be very sure that we are not going to be also destroying a vital role in a normal process such as the body's immune system."

'"/>

Contact: Sarah L. White, Ph.D.
swhite@licr.org
212-450-1543
Ludwig Institute for Cancer Research
11-May-2006

Page: 1
Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. Reduced greenhouse gas emissions required to avoid dangerous increases in heat stress
3. OCT1 required for therapeutic effects of diabetes drug Metformin
4. Malignant melanoma cells secrete protein required for embryo formation
5. Urgent action required to tackle escalating road-traffic crashes worldwide
6. Scientists develop method to track immune system enzyme in live animals
7. Thymus transplants gives hope to babies with fatal immune disease
8. Vitamin D supplements may offer cheap and effective immune system boost against TB
9. Stanford researchers identify immune dysfunction in melanoma patients
10. Head and neck cancer vaccine targets proteins to create immune response
11. Weak immune response critical to disease that causes most infant hospitalizations